CHINA COVID-19 antigen self-testing kits produced at Biouhan healthcare company in Hefei, E China

CHINA

COVID-19 antigen self-testing kits produced at Biouhan healthcare company in Hefei, E China

China.org.cn

09:56, April 03, 2022

Staff members work at a production line of COVID-19 self-testing kits at Biouhan healthcare company in Hefei, east China's Anhui Province, March 29, 2022. Since March 11, China has added antigen detection as an option for COVID-19 testing among the public. Such kits are already seen in drug stores, online platforms and multiple detection scenarios in China. With a capacity of up to 10 million kits per day, Biouhan healthcare company is a major manufacturer of COVID-19 antigen self-testing kits in east China's Anhui Province. The testing kits have been used in transportation hubs in Hefei, Anhui Province. (Xinhua/Du Yu)

A staff member works at a production line of COVID-19 self-testing kits at Biouhan healthcare company in Hefei, east China's Anhui Province, March 29, 2022. Since March 11, China has added antigen detection as an option for COVID-19 testing among the public. Such kits are already seen in drug stores, online platforms and multiple detection scenarios in China. With a capacity of up to 10 million kits per day, Biouhan healthcare company is a major manufacturer of COVID-19 antigen self-testing kits in east China's Anhui Province. The testing kits have been used in transportation hubs in Hefei, Anhui Province. (Xinhua/Du Yu)

A staff member works at a production line of COVID-19 self-testing kits at Biouhan healthcare company in Hefei, east China's Anhui Province, March 29, 2022. Since March 11, China has added antigen detection as an option for COVID-19 testing among the public. Such kits are already seen in drug stores, online platforms and multiple detection scenarios in China. With a capacity of up to 10 million kits per day, Biouhan healthcare company is a major manufacturer of COVID-19 antigen self-testing kits in east China's Anhui Province. The testing kits have been used in transportation hubs in Hefei, Anhui Province. (Xinhua/Du Yu)

Staff members work at a production line of COVID-19 self-testing kits at Biouhan healthcare company in Hefei, east China's Anhui Province, March 29, 2022. Since March 11, China has added antigen detection as an option for COVID-19 testing among the public. Such kits are already seen in drug stores, online platforms and multiple detection scenarios in China. With a capacity of up to 10 million kits per day, Biouhan healthcare company is a major manufacturer of COVID-19 antigen self-testing kits in east China's Anhui Province. The testing kits have been used in transportation hubs in Hefei, Anhui Province. (Xinhua/Du Yu)

Staff members work at a production line of COVID-19 self-testing kits at Biouhan healthcare company in Hefei, east China's Anhui Province, March 29, 2022. Since March 11, China has added antigen detection as an option for COVID-19 testing among the public. Such kits are already seen in drug stores, online platforms and multiple detection scenarios in China. With a capacity of up to 10 million kits per day, Biouhan healthcare company is a major manufacturer of COVID-19 antigen self-testing kits in east China's Anhui Province. The testing kits have been used in transportation hubs in Hefei, Anhui Province. (Xinhua/Du Yu)

A staff member shows a COVID-19 antigen self-testing kit at Biouhan healthcare company in Hefei, east China's Anhui Province, March 29, 2022. Since March 11, China has added antigen detection as an option for COVID-19 testing among the public. Such kits are already seen in drug stores, online platforms and multiple detection scenarios in China. With a capacity of up to 10 million kits per day, Biouhan healthcare company is a major manufacturer of COVID-19 antigen self-testing kits in east China's Anhui Province. The testing kits have been used in transportation hubs in Hefei, Anhui Province. (Xinhua/Du Yu)

A staff member works at a production line of COVID-19 self-testing kits at Biouhan healthcare company in Hefei, east China's Anhui Province, March 29, 2022. Since March 11, China has added antigen detection as an option for COVID-19 testing among the public. Such kits are already seen in drug stores, online platforms and multiple detection scenarios in China. With a capacity of up to 10 million kits per day, Biouhan healthcare company is a major manufacturer of COVID-19 antigen self-testing kits in east China's Anhui Province. The testing kits have been used in transportation hubs in Hefei, Anhui Province. (Xinhua/Du Yu)

Terms of Service & Privacy Policy

We have updated our privacy policy to comply with the latest laws and regulations. The updated policy explains the mechanism of how we collect and treat your personal data. You can learn more about the rights you have by reading our terms of service. Please read them carefully. By clicking AGREE, you indicate that you have read and agreed to our privacy policies

Agree and continue